Next-gen biotech Caribou Biosciences nabs Array (now Pfizer) cancer R&D exec as clinical lead May 12, 2020
Shift Technology and Snapsheet Partner to Add Fraud Detection to Snapsheet Claims Management Platform May 11, 2020
Tempest Therapeutics Announces First Patient Dosed in TPST-1495 Clinical Study: Dual EP2/4 Antagonist Targeting Solid Tumors May 7, 2020
FARAPULSE’s Pioneering Clinical Results Link Compelling Long-term Outcomes to Established Safety and Lesion Durability Data May 7, 2020
Owkin raises $25 million as it builds a secure network for healthcare analysis and research May 7, 2020
Tradier Teams With Q.ai, A Forbes Company, To Bring AI And Big Data Analytics To Customers And Retail Investors May 7, 2020
Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer May 6, 2020